Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

Little information exists regarding Ebola vaccine rVSVΔG-ZEBOV-GP and pregnancy. The Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE) randomized participants without blinding to immediate or deferred (18–24 weeks postenrollment) vaccination. Pregnancy was an exclusion criterion, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Legardy-Williams, Jennifer K., Carter, Rosalind J., Goldstein, Susan T., Jarrett, Olamide D., Szefer, Elena, Fombah, Augustin E., Tinker, Sarah C., Samai, Mohamed, Mahon, Barbara E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045819/
https://www.ncbi.nlm.nih.gov/pubmed/32017677
http://dx.doi.org/10.3201/eid2603.191018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045819/
https://www.ncbi.nlm.nih.gov/pubmed/32017677
http://dx.doi.org/10.3201/eid2603.191018

Ejemplares similares